CTM@CRC LTD has a total of 11 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2016. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, medical technology and pharmaceuticals are DESMOS INC, B R A I N BIOTECHNOLOGY RES AN and PROTEIN POLYMER TECH INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | Australia | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | United States | 2 | |
#5 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Medical technology | |
#3 | Pharmaceuticals | |
#4 | Macromolecular chemistry and polymers |
# | Technology | |
---|---|---|
#1 | Object sterilising | |
#2 | Peptides | |
#3 | Microorganisms | |
#4 | Medical preparations | |
#5 | Therapeutic chemical compounds | |
#6 | Special macromolecular compounds |
# | Name | Total Patents |
---|---|---|
#1 | Voelcker Nicolas Hans | 6 |
#2 | Hutmacher Dietmar | 5 |
#3 | Wunner Felix | 5 |
#4 | Pardo Maria Elena Juan | 5 |
#5 | Barry Simon | 5 |
#6 | Gundsambuu Batjargal | 5 |
#7 | Delalat Bahman | 5 |
#8 | Cowin Allison June | 4 |
#9 | Kirby Giles Thomas Sipho | 4 |
#10 | Smith Louise Elizabeth | 4 |
Publication | Filing date | Title |
---|---|---|
WO2017156592A1 | Anti-fouling and/or anti-thrombotic medical devices | |
WO2017041143A1 | Chimeric antigen receptors and uses thereof | |
US2018371413A1 | Products and methods for activating and/or expanding t cells | |
EP3258978A1 | Methods and products for delivering cells |